Novo CEO pressed by Senate to cut selling prices of obesity, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the business would take into consideration new talks with insurers regarding the listing prices of Wegovy and copyright if they pledge to keep the medicines on their own formularies. https://dave-s-hot-chicken-nutrit83827.angelinsblog.com/30092248/details-fiction-and-healthcare-news